Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.
Company Details
- Employees
- 137
- Founded
- -
- Address
- 2929 7th St, Suite 105, Berkeley,ca 94710,united States
- Phone
- 510-982-6030
- in****@****ces.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cariboubio.com
- Keywords
- Next-generation CRISPR genome editing, allogeneic CAR-T cell therapies, oncology, autoimmune.
- HQ
- Berkeley, CA
Caribou Biosciences Questions
Caribou Biosciences's helpline number is 510-982-6030
Caribou Biosciences's website is cariboubio.com
Caribou Biosciences's LinkedIn profile is https://www.linkedin.com/company/caribou-biosciences
Caribou Biosciences has
137 employees.
View email and phone details for 137
employees at Caribou Biosciences.
Caribou Biosciences's industry is
Biotechnology Research
Caribou Biosciences's top competitors are
Beam Therapeutics,
Sana Biotechnology, Inc.,
Denali Therapeutics,
Allogene Therapeutics,
Twist Bioscience,
Kyverna Therapeutics,
Ginkgo Bioworks, Inc.,
Genentech,
Arsenal Biosciences, Inc.,
Mammoth Biosciences.
Caribou Biosciences's support email address is info@cariboubiosciences.com
Caribou Biosciences's categories are Biotechnology Research
Caribou Biosciences's founding year is 2012
